Lycorine and its derivatives for anticancer drug design

Mini-Reviews in Medicinal Chemistry

Volumn 10, Issue 1, 2010, Pages 41-50

  Lamoral Theys, D ^a   Decaestecker, C ^a   Mathieu, V ^a   Dubois, J ^a   Kornienko, A ^b   Kiss, R ^a   Evidente, A ^c   Pottier, L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b NEW MEXICO INSTITUTE OF MINING AND TECHNOLOGY   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 O ACETYLLYCORINE; 1 O ACETYLNORPLUVIINE; 1,2 DI O ACETYL ALPHA DIHYDROLYCORINE; 2 O ACETYLPSEUDOLYCORINE; ALKENE; AMARBELLISINE; AMARYLLIDACEAE ALKALOID; AMINE; ANHYDROLYCORINIUM; ANHYDROLYCORINONE; ANTINEOPLASTIC AGENT; CRISIATICIDINE A; DIACETYLLYCORINE; DIACETYLLYCORINONE; GALANTHINE; LYCORENE; LYCORINE; LYCORINE 2 ONE; N METHYLLYCORINE; NORPLUVIINE; PRATORIMINE; PSEUDOLYCORIN; STERNBERGINE; UNCLASSIFIED DRUG; UNGEREMINE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; DRUG DESIGN; DRUG STRUCTURE; LEUKEMIA; LYMPHATIC LEUKEMIA; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG DESIGN; HUMANS; NEOPLASMS; PHENANTHRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77951143131     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955710791112604     Document Type: Review

References (56)

1. Lefranc, F.; Brotchi, J.; Kiss, R. Possible future in the treatment of glioblastoma: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol., 2005, 23, 2411-2422
2. Soengas, M.S.; Low, S.W. Apoptosis and melanoma chemoresistance. Oncogene, 2003, 22, 3138-3151
3. D'Amico, T.A.; Harpole, D.H. Jr. Molecular biology of esophageal cancer. Chest Surg. Clin. N. Am., 2000, 10, 451-469
4. El Maalouf, G.; Le Tourneau, C.; Batty, G.N.; Faivre, S.; Raymond, E. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer. Cancer Treat. Rev., 2009, 35, 167-174
5. Viktorsson, K.; De Petris, L.; Lewensohn, R. The role of p53 in treatment responses of lung cancer. Biochem. Biophys. Res. Commun., 2005, 331, 868-880
6. Wilson, T.R.; Johnston, P.G.; Longley, D.B. Anti-apoptotic mechanisms of drug resistance in cancer. Curr. Cancer Drug Targets, 2009, 9, 307-319
7. Katsman, A.; Umezawa, K.; Bonavida, B. Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. Curr. Pharm. Res., 2009, 15, 792-808.
8. Lefranc, F.; Rynkowski, M.; De Witte, O.; Kiss, R. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv. Tech. Stand. Neurosurg., 2009, 34, 3-35.
9. Klein, S.; McCormick, F.; Levitzki, A. Killing time for cancer cells. Nat. Rev. Cancer, 2005, 5, 573-580
10. Decaestecker, C.; Debeir, O.; Van Ham, P.; Kiss, R. Can antimigratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration. Med. Res. Rev., 2007, 27, 149-176
11. Barthomeuf, C.; Bourguet-Kondracki, M.L.; Kornprobst, J.M. Marine metabolites overcoming or circumventing multidrug resistance mediated by ATP-dependent transporters: a new hope for patient with tumors resistant to conventional chemotherapy. Anticancer Agents Med. Chem., 2008, 8, 886-903.
12. Werle, M. Natural and synthetic polymers as inhibitors of drug efflux pumps. Pharm. Res., 2008, 25, 500-511
13. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 2003, 66, 1020-1037
14. Kornienko, A.; Evidente, A. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem Rev., 2008, 108, 1982-2014.
15. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction=Search.Search-Drug-Name (search for RAZADYNE)
16. Jin, Z. Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep., 2009, 26, 363-381
17. Appukkuttan, P.; Van der Eycken, E. An overview of syntheses of apogalanthamine analogues and 7-aza derivatives of steganacin and steganone. Eur. J. Org. Chem., 2008, 35, 5867-5886
18. Manpadi, M.; Kornienko, A. Total syntheses of pancratistatin. A review. Org. Prep. Proc. Int., 2008, 40, 107-161
19. Jin, Z. Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep., 2007, 24, 886-905.
20. Unver, N. New skeletons and new concepts in Amaryllidaceae alkaloids. Phytochem. Rev., 2007, 6, 1, 125-135
21. Wilson R.M.; Danishefsky, S. J. Applications of total synthesis toward the discovery of clinically useful anticancer agents. Chem. Soc. Rev., 2007, 36, 1207-1226
22. Fuganti, C.; Mazza, M. Late intermediates in the biosynthesis of narciclasine. J. Chem. Soc. D Chem. Commun., 1971, 21, 1388-1389
23. Eichhorn, J.; Takada, T.; Kita, Y.; Zenk, M.H. Biosynthesis of the Amaryllidaceae alkaloid galanthamine. Phytochemistry, 1998, 49, 1037-1047
24. Franck, B.; Lubs, H.J.; Alkaloid syntheses by oxidative condensation under biogenetic conditions. X. Model reaction for the biosynthesis of the crinine alkaloids. Angew. Chem, Int. Ed. Eng., 1968, 7, 223.
25. Battersby, A.R.; Binks, R.; Breuer, S.W.; Fales, H.M.; Wildman, W.C.; Highet, R.J. Alkaloid biosynthesis. III. Amaryllidaceae alkaloids: the biosynthesis of lycorine and its relatives. J. Chem. Soc., 1964, 1595-1609.
26. Wildman, W.C.; Oleson, B. Biosynthesis of montanine. J. Chem. Soc. Chem. Commun., 1976, 14, 551.
27. Fuganti, C.; Mazza, M. Relative stereochemistry of protonation and hydroxylation in the biosynthesis of lycorenine and hemanthidine from protocatechualdehyde. J. Chem. Soc. D Chem. Commun., 1971, 19, 1196-1197
28. Evidente, A.; Kornienko, A. Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their derivatives. Phytochem. Rev., 2009, 8, 449-459
29. Evidente, A.; Kireev, A.S.; Jenkins, A.R.; Romero, A.E.; Steelant, W.F.A.; Van Slambrouck, S.; Kornienko, A. Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: Discovery of novel leads for anticancer drug design. Planta Med., 2009, 75, 501-507
30. Liu, X.S.; Jiang, J.; Jiao, X.Y.; Wu, Y.; Lin, J.; Cai, Y. Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. Cancer Lett., 2009, 274, 16-24.
31. Li, Y.; Liu, J.; Tang, L.J.; Shi, Y.W.; Hu, W.X. Treatment of lycorine on SCID mice model with human APL cells. Biomed Pharmacother. 2007, 61, 229-234
32. Jokhadze, M.; Eristavi, L.; Kutchukhidze, J.; Chariot, A.; Angenot, L.; Tits, M.; Jansen, O.; Frédérich, M. In vitro cytotoxicity of some medicinal plants from Georgian Amaryllidaceae. Phytother. Res., 2007, 21, 622-624
33. Li, Y.; Liu, J.; Tang, L.J.; Zhang, G.P.; Ren, W.; Hu, W.X. Apoptosis induced by Lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncol Rep., 2007, 17, 377-384
34. Lin, L.Z.; Hu, S.F.; Chai, H.B.; Pengsuparp, T.; Pezzuto, J.; Cordell, GA.; Ruangrungsi, N. Lycorine alkaloids from Hymenocallis littoralis. Phytochemistry, 1995, 40, 1295-1298
35. Weniger, B.; Italiano, L.; Beck, J.-P.; Bastida, J.; Bergoñon, S.; Codina, C.; Lobstein, A.; Anton, R. Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med., 1995, 61, 77-79
36. Campbell, W.E.; Nair, J.J;. Gammon, D.W.; Bastida, J.; Codina, C.; Viladomat, F.; Smith, P.J.; Albrecht, C.F. Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis. Planta Med., 1998, 64, 91-93
37. Ghosal, S.; Singh, S. K.; Kumar, Y.; Unnikrishnan, S.; Chattopadhyay, U. The role of ungeremine in the growth-inhibiting and cytotoxic effects of lycorine: evidence and speculation. Planta Med., 1988, 54, 114-116
38. Campbell, W.E.; Nair, J.J;. Gammon, D.W.; Codina, C.; Bastida, J.; Viladomat, F.; Smith, P.J.; Albrecht, C.F. Bioactive alkaloids from Brunsvigia radulosa. Phytochemistry, 2000, 53, 587-591
39. Evidente, A.; Iasiello, I.; Randazzo, G. Isolation of sternbergine, a new alkaloid from bulbs of Sternbergia lutea. J. Nat. Prod., 1984, 47, 1003-1008
40. Evidente, A.; Andolfi, A.; Abou-Donia, A.H., Touema, S.M. Hommoda, H.M.; Shawsky E.; Motta A. Amarbellisine, a lycorinetype alkaloid from Amaryllis belladonna L. growing in Egypt. Phtytochemistry, 2004, 65, 2113-2118
41. http://pubchem.ncbi.nlm.nih.gov/search/search.cgi (structure search)
42. Min, B.S.; Gao, J.J.; Nakamura, N.; Kim, Y.H.; Hattori, M. Cytotoxic alkaloids and a flavan from the bulb of Crinum asiaticum var. japonicum. Chem. Pharm. Bull., 2001, 49, 1217-1219
43. Abd El Hafiz, M.A.; Ramadan, M.A.; Jung, M.L.; Beck, J.P.; Anton, R. Cytotoxic activity of amaryllidace alkaloids from Crinum augustum and Crinum bulbispermum. Planta Med., 1991, 57, 437-439
44. Evidente, A.; Randazzo, G.; Surici, G.; Lavermicocca, P.; Arrigoni, O. Degradation of lycorine by Pseudomonas species strani ITM 331. J. Nat. Prod., 1985, 48, 564-570
45. Humber, L.G.; Kondo, H.; Kotera, K.; Takagi, K.; Takeda, W.L.; Taylor, B.R. ; Thomas, Y.; Tsuda, K.; Tsukamoto, K; Uyeo, S.; Yajima, H.; Yanaihara, N. Lycorine alkaloids. Part XXVIII. The constitution of lycorine and the synthesis of its degradation products. J. Chem. Soc., 1954, 4622-4630
46. Zee-Cheng, R.K.-Y.; Yan, S.-J.; Cheng, C.C. Antileukemic activity of ungeremine and related compounds. Preparation of analogues of ungeremine by a practical photochemical reaction. J. Med. Chem., 1978, 21, 199-203.
47. Abou-Donia, A.H.; Abib, A.A.; el Din A.S.; Evidente, A.; Gaber, M.; Scopa, A. Two beatine-type alkaloids from bulbs of Pancratium maritimum. Phytochemistry, 1992, 22, 2139-2141
48. Pettit, G.R.; Meng, Y.; Herald, D.L.; Knight, J.C.; Day, J.F. Antineoplastic agents. 553. The Texas grasshopper Brachystola magna. J. Nat. Prod., 2005, 68, 1256-1258
49. Barthelmes, H. U.; Niederberger, E.; Roth, T.; Schulte, K.; Tang, W. C.; Boege, F.; Fiebig, H.-H.; Eisenbrand, G.; Marko, D. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells. Br. J. Cancer, 2001, 85, 1585-1591
50. Jimenez, A.; Santos, A.; Alonzo, G.; Vasquez, D. Inhibitors of protein synthesis in eukaryotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochim. Biophys. Acta Nucleic Acids Protein Synth., 1976, 425, 342-348
51. Vrijsen, R.; Vanden Berghe, D.A.; Vlietinck, A.J.; Boeyé, A. Lycorine: a eukaryotic termination inhibitor? J. Biol. Chem., 1986, 261, 505-507
52. Kukhanova, M.; Victorova, L.; Krayevsky, A. Peptidyltransferase center of ribosomes. On the mechanism of action of alkaloid lycorine. FEBS Lett., 1983, 160, 129-133
53. Arrigoni, O. Ascorbate system in plant development. J. Bioenerg. Biomembr., 1994, 26, 407-419
54. Liu, J.; Hu, W.X.; He, L.F.; Ye, M.; Li, Y. Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS Lett., 2004, 578, 245-250
55. Yui, S.; Mikami, M.; Kitahara, M.; Yamazaki, M. The inhibitory effect of lycorine on tumour cell apoptosis induced by polymorphonuclear leukocyte-derived calprotectin. Immunopharmacology, 1998, 151-162
56. Karadeniz, H.; Gulmez, B.; Sahinci, F.; Erdem, A.; Kaya, G.I.; Unver, N.; Kivcak, B.; Ozsoz, M. Disposable electrochemical biosensor for the detection of the interaction between DNA and lycorine based on guanine and adenine signals. J. Pharm. Biomed. Anal., 2003, 33, 295-302.